arrow
R

Rory M. Shallis

Yale School of Medicine
H指数:26
被引数:3,762

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The PRIME trial: An investigator-initiated, multicentre, phase II study of the poly(ADP-ribose) polymerase inhibitor olaparib in isocitrate dehydrogenase (IDH)-mutated relapsed/refractory acute myeloid leukaemia and myelodysplastic syndromes

PRIME试验:一项由研究者发起的多中心II期研究,评估聚(ADP-核糖)聚合酶抑制剂奥拉帕利在异柠檬酸脱氢酶(IDH)突变复发/难治性急性髓系白血病和骨髓增生异常综合征中的应用

2026-09-060
OAAI
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

费城染色体阳性急性淋巴细胞白血病(ALL)患者完全分子缓解的预测因素及异基因造血干细胞移植对预后的影响:来自骨髓恶性肿瘤和肿瘤疾病联盟(COMMAND)的结果

2026-06-071
PRE
Outcomes of older patients with TP53-mutated myeloid neoplasms

TP53突变髓系肿瘤老年患者的结局

2025-10-070
OA
Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab

RNA剪接因子突变AML和高风险MDS接受阿扎胞苷±度鲁瓦图单抗治疗后的整合免疫景观分析

2025-06-210
OA
Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status

TP53突变性骨髓增殖性肿瘤的结局异质性,基于疾病表型和突变状态

2025-05-220
PRE
The Prognostic and Predictive Value of RUNX1 Mutations in Newly Diagnosed Acute Myeloid Leukemia- an International Multicenter Cohort Study

RUNX1突变在初诊急性髓系白血病中的预后和预测价值——一项国际多中心队列研究

BLOOD
IF23.1
2024-11-050
PRE
Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2)

培美曲塞联合阿扎胞苷和维奈克拉用于急性髓系白血病患者的疗效与安全性:一项研究者发起、多中心、CTEP资助的随机、Ⅱ期试验(BLAST AML-2)的结果

BLOOD
IF23.1
2024-11-050
PRE
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML
2024-09-131
OAAI
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study
2024-09-100
PRE